SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-071385
Filing Date
2023-06-15
Accepted
2023-06-15 06:41:48
Documents
14
Period of Report
2023-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318791d1_8k.htm   iXBRL 8-K 33481
2 EXHIBIT 10.1 tm2318791d1_ex10-1.htm EX-10.1 30635
  Complete submission text file 0001104659-23-071385.txt   291080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA toi-20230614.xsd EX-101.SCH 3545
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toi-20230614_def.xml EX-101.DEF 26813
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE toi-20230614_lab.xml EX-101.LAB 37137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toi-20230614_pre.xml EX-101.PRE 25435
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2318791d1_8k_htm.xml XML 5440
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 231015917
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine